Statistics from Altmetric.com
Febrile neutropenia (FN) is the most common life-threatening complication of treatment for childhood cancer.1 The UK Children’s Cancer and Leukaemia Group (CCLG) have conducted two previous national audits to assess practice against the standards described in the 2012 NICE CG151 guidelines on neutropenia sepsis.2–4 These demonstrated improvements in assessment and ongoing management of episodes of FN but variations in care persisted. In winter 2017, we conducted a further audit to assess progress. The methods were similar to previous years to allow for comparison with earlier data, though the timing changed to capture data over the winter period when units might be expected to …
Contributors BP and JM designed and ran the audit. JM analysed the data and provided the first draft of the manuscript. BP provided critique of the analysis and substantially redrafted the manuscript. Both authors have approved the final version.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient consent Not required.
Provenance and peer review Not commissioned; internally peer reviewed.
Collaborators on behalf of the Children’s Cancer and Leukaemia Group Supportive Care Group.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.